Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.
As part of our mission to end cardiovascular disease, The Minneapolis Heart Institute Foundation offers weekly cardiology Grand Rounds to stay up-to-date on the latest developments in cardiology. These weekly meetings feature topics from the following cardiac specialty areas: congestive heart failure, electrophysiology, cardiac imaging, interventional cardiology, heart disease prevention, cardiac surgery, vascular/endovascular and miscellaneous.
Monday, December 19, 2011
Monday, November 28, 2011
TCT/AHA Highlights: Platelets and Stem Cells
Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME, SCIPIO and CADUCEUS trials.
Monday, November 21, 2011
Update in Preventive Cardiology 2011
Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.
Monday, October 31, 2011
AHA Abstract Presentations
Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris
Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter
Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed
Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema
Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter
Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed
Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema
Monday, October 24, 2011
Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?
Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.
Monday, October 17, 2011
Repairing Valves: Why and Why Not?
Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.
Monday, October 3, 2011
Cardiac Resynchronization Therapy: Developing a Center of Excellence
Dr. Alan J. Bank, Medical Director of Research at United Heart and
Vascular Clinic, and
Associate Professor of Cardiology at the University of
Minnesota, describes the components of a CRT Center
of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical
dyssynchrony in heart failure, and describes the effects of CRT in patients
with NYHA Class II heart failure.
Monday, September 26, 2011
A Serious Complication of a Common Vascular Practice
Dr. Nedaa Skeik, Vascular Medicine Consultant at the Minneapolis Heart
Institute® at
Abbott Northwestern Hospital, explains different treatment modalities
for deep vein thrombosis (DVT), describes the history of inferior vena
cava (IVC) filters, lists indications and
complications (common and rare) of IVC filters, and explains identification and management
of arterial pseudoaneurysm as a rare complication of IVC filters.
Monday, September 19, 2011
Sudden Death, Risk Stratification and Prevention in Hypertrophic Cardiomyopathy
Dr. Barry J. Maron, Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.
Monday, September 12, 2011
Pacing the Heart: What side are you on?
Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott-Northwestern Hospital, Dr. Robert Hauser, summarizes pacing
hemodynamics, describes the
value of cardiac synchronization, and explains ICD
reliability and patient longevity.
Subscribe to:
Posts (Atom)